Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Wright

Clinical Cardiac Electrophysiology Madison, WI Medical Doctor

NPI 1669661013 CMS profile 609804

600 Highland Ave, Madison, WI 53792

Open in the dashboard

General payments

$34,866

53 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Wright of Madison, WI is reported in the CMS Open Payments database as having received $34,866 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,005 17
2024 General $10,618 14
2023 General $6,942 7
2022 General $1,911 5
2021 General $8,550 6
2019 General $840 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Wright
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jennifer Wright were reported at $6,005. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jennifer Wright Clinical Cardiac Electrophysiology median Middle half National median
2019 $840 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $8,550 $1,185 $326–$4,739 $132
2022 $1,911 $2,073 $554–$6,789 $149
2023 $6,942 $2,568 $759–$8,159 $160
2024 $10,618 $2,557 $703–$7,403 $164
2025 $6,005 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biosense Webster, Inc. $11,303 16 payments
  2. Medical Device Business Services, Inc. $10,238 9 payments
  3. Edwards Lifesciences Corporation $6,894 4 payments
  4. Boston Scientific Corporation $4,959 16 payments
  5. Abbott Laboratories $1,264 3 payments
  6. Atricure, Inc. $131 1 payment
  7. Alexion Pharmaceuticals, Inc. $34 1 payment
  8. GlaxoSmithKline, LLC. $16 1 payment
  9. Novo Nordisk Inc $15 1 payment
  10. Allergan Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $26,988 19 payments
  2. Travel and Lodging $4,316 12 payments
  3. Food and Beverage $2,312 20 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,250 2 payments
Products named General payments · program years 2019–2025
  1. Carto 3 $21,481 25 payments
  2. FARAPULSE Farapulse_Rm $2,236 6 payments
  3. FARAPULSE Farapulse_Ep $1,284 4 payments
  4. Ensite Cardiac Mapping System $675 1 payment
  5. ENSITE PRECISION $589 2 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $131 1 payment
  7. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $131 1 payment
  8. Carto 3 System $118 1 payment
  9. Soundstar $118 1 payment
  10. General - Therapies $46 1 payment
  11. Other $79 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 22 drugs

Part D claims

1,353

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$543,092

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

35.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 336 $441,040
Xarelto Rivaroxaban Brand 41 $64,571
Farxiga Dapagliflozin Propanediol Brand 11 $14,403
Flecainide Acetate Generic 149 $5,347
Metoprolol Succinate Generic 270 $5,332
Amiodarone Hcl Generic 143 $3,326
Candesartan Cilexetil Generic 21 $2,111
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 54 $1,213
Irbesartan Generic 28 $1,163
Nadolol Generic 25 $1,064

The 10 drugs with the highest cost, of 22 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$108,733

Medicare's payments for the services billed

Medicare patients

743

Average age 75

Services billed

1,988

352 women, 391 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 57%
Ischemic heart disease 42%
Arthritis 42%
Heart failure 41%
Chronic kidney disease 35%
Diabetes 32%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record